1. A fatal case associated with Catabacter hongkongensis bacteremia in lung cancer patient: A case report. (2022) Authors: Mandin, Valentin; Corvec, Stéphane; Chéné, Anne-Laure; Guillouzouic, Aurélie; Dirou, Stéphanie; Bennouna, Jaafar; Bémer, Pascale; Pons-Tostivint, Elvire Journal: IDCases Issue: Volume 29(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial). (December 2022) Authors: Argilés, Guillem; Mulet, Nuria; Valladares-Ayerbes, Manuel; Viéitez, José M.; Grávalos, Cristina; García-Alfonso, Pilar; Santos, Cristina; Tobeña, María; García-Paredes, Beatriz; Benavides, Manuel; Cano, María T.; Loupakis, Fotios; Rodríguez-Garrote, Mercedes; Rivera, Fernando; Goldberg, Richard ... Journal: European journal of cancer Issue: Volume 177(2022) Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin‐bound paclitaxel with or without CC‐486 as second‐line treatment for advanced nonsquamous non‐small cell lung cancer (NSCLC). Issue 24 (1st November 2018) Authors: Morgensztern, Daniel; Cobo, Manuel; Ponce Aix, Santiago; Postmus, Pieter E.; Lewanski, Conrad R.; Bennouna, Jaafar; Fischer, Jürgen R.; Juan‐Vidal, Oscar; Stewart, David J.; Fasola, Gianpiero; Ardizzoni, Andrea; Bhore, Rafia; Wolfsteiner, Marianne; Talbot, Denis C.; Jin Ong, Teng; Govindan, Ramas... Journal: Cancer Issue: Volume 124:Issue 24(2018) Page Start: 4667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials. Issue 2 (February 2015) Authors: Yang, James Chih-Hsin; Wu, Yi-Long; Schuler, Martin; Sebastian, Martin; Popat, Sanjay; Yamamoto, Nobuyuki; Zhou, Caicun; Hu, Cheng-Ping; O'Byrne, Kenneth; Feng, Jifeng; Lu, Shun; Huang, Yunchao; Geater, Sarayut L; Lee, Kye Young; Tsai, Chun-Ming; Gorbunova, Vera; Hirsh, Vera; Bennouna, Jaafar; Or... Journal: Lancet oncology Issue: Volume 16:Issue 2(2015:Feb.) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials. Issue 2 (February 2015) Authors: Yang, James Chih-Hsin; Wu, Yi-Long; Schuler, Martin; Sebastian, Martin; Popat, Sanjay; Yamamoto, Nobuyuki; Zhou, Caicun; Hu, Cheng-Ping; O'Byrne, Kenneth; Feng, Jifeng; Lu, Shun; Huang, Yunchao; Geater, Sarayut L; Lee, Kye Young; Tsai, Chun-Ming; Gorbunova, Vera; Hirsh, Vera; Bennouna, Jaafar; Or... Journal: Lancet oncology Issue: Volume 16:Issue 2(2015:Feb.) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Afatinib-based combination regimens for the treatment of solid tumors: rationale, emerging strategies and recent progress. (February 2016) Authors: Bennouna, Jaafar; Moreno Vera, Shanti Ricardo Journal: Future oncology Issue: Volume 12:Number 3(2016) Page Start: 355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Anti-angiogenic-specific adverse events in patients with non-small cell lung cancer treated with nintedanib and docetaxel. Issue 2 (November 2015) Authors: Reck, Martin; Mellemgaard, Anders; von Pawel, Joachim; Gottfried, Maya; Bondarenko, Igor; Cheng, Ying; Zarogoulidis, Kostas; Luft, Alexander; Bennouna, Jaafar; Barrueco, José; Aboshady, Hesham; Hocke, Julia; Kaiser, Rolf; Douillard, Jean-Yves Journal: Lung cancer Issue: Volume 90:Issue 2(2015:Nov.) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Combination of Trastuzumab, Pertuzumab, and Docetaxel in Patients With Advanced Non–Small-Cell Lung Cancer Harboring HER2 Mutations: Results From the IFCT-1703 R2D2 Trial. Issue 7 (1st March 2022) Authors: Mazieres, Julien; Lafitte, Claire; Ricordel, Charles; Greillier, Laurent; Negre, Elodie; Zalcman, Gérard; Domblides, Charlotte; Madelaine, Jeannick; Bennouna, Jaafar; Mascaux, Céline; Moro-Sibilot, Denis; Pinquie, François; Cortot, Alexis B.; Otto, Josiane; Cadranel, Jacques; Langlais, Alexandra;... Journal: Journal of clinical oncology Issue: Volume 40:Issue 7(2022) Page Start: 719 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Development and long‐term stability of a comprehensive daily QA program for a modern pencil beam scanning (PBS) proton therapy delivery system. Issue 4 (28th March 2019) Authors: Rana, Suresh; Bennouna, Jaafar; Samuel, E. James Jebaseelan; Gutierrez, Alonso N. Journal: Journal of applied clinical medical physics Issue: Volume 20:Issue 4(2019) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects. (July 2017) Authors: Pernot, Simon; Badoual, Cecile; Terme, Magali; Castan, Florence; Cazes, Aurelie; Bouche, Olivier; Bennouna, Jaafar; Francois, Eric; Ghiringhelli, Francois; De La Fouchardiere, Christelle; Samalin, Emmanuelle; Bachet, Jean Baptiste; Borg, Christophe; Ducreux, Michel; Marcheteau, Elie; Stanbury, Tr... Journal: European journal of cancer Issue: Volume 79(2017) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗